BETTELLI, Stefania Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.501
AS - Asia 4.116
EU - Europa 3.970
SA - Sud America 595
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 100
OC - Oceania 7
Totale 18.429
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.314
SG - Singapore 1.232
GB - Regno Unito 1.030
CN - Cina 949
IT - Italia 910
HK - Hong Kong 464
BR - Brasile 443
VN - Vietnam 435
DE - Germania 402
SE - Svezia 356
BD - Bangladesh 312
IE - Irlanda 287
FI - Finlandia 208
UA - Ucraina 162
RU - Federazione Russa 153
FR - Francia 137
TR - Turchia 120
IN - India 118
CA - Canada 100
KR - Corea 81
JP - Giappone 75
ID - Indonesia 73
BG - Bulgaria 62
AR - Argentina 53
NL - Olanda 52
MX - Messico 42
PL - Polonia 41
IQ - Iraq 34
ZA - Sudafrica 30
PK - Pakistan 29
CO - Colombia 25
BE - Belgio 23
LT - Lituania 22
AT - Austria 20
MY - Malesia 20
AE - Emirati Arabi Uniti 18
CL - Cile 18
VE - Venezuela 18
CZ - Repubblica Ceca 16
EC - Ecuador 16
ES - Italia 16
SA - Arabia Saudita 16
UZ - Uzbekistan 15
EG - Egitto 13
CR - Costa Rica 11
IR - Iran 11
MA - Marocco 11
PH - Filippine 11
TH - Thailandia 11
TW - Taiwan 11
CH - Svizzera 10
RO - Romania 10
AZ - Azerbaigian 9
NP - Nepal 9
DK - Danimarca 8
JO - Giordania 8
KE - Kenya 8
LB - Libano 8
PY - Paraguay 8
TN - Tunisia 8
IL - Israele 7
PE - Perù 7
AU - Australia 6
BH - Bahrain 6
JM - Giamaica 6
DZ - Algeria 5
EU - Europa 5
GR - Grecia 5
GT - Guatemala 5
PT - Portogallo 5
RS - Serbia 5
BO - Bolivia 4
GA - Gabon 4
GE - Georgia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NO - Norvegia 4
TZ - Tanzania 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EE - Estonia 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BZ - Belize 2
CY - Cipro 2
HN - Honduras 2
HU - Ungheria 2
ME - Montenegro 2
MK - Macedonia 2
MT - Malta 2
Totale 18.258
Salva come PNG Salva come JPEG
Città #
Ashburn 930
Singapore 833
Santa Clara 832
Fairfield 817
Southend 660
Chandler 497
Hong Kong 454
Woodbridge 439
San Jose 435
Houston 360
Seattle 347
Ann Arbor 294
Dublin 286
Cambridge 284
Wilmington 267
Jacksonville 266
Dearborn 260
Council Bluffs 256
Beijing 227
Nyköping 226
Hefei 202
Los Angeles 176
New York 172
London 167
Chicago 164
Ho Chi Minh City 145
Helsinki 144
Dallas 118
The Dalles 116
Modena 113
Hanoi 101
Munich 83
Milan 80
Salt Lake City 78
Seoul 75
Izmir 68
Tokyo 66
San Diego 62
Lauterbourg 61
Princeton 60
Columbus 57
Sofia 57
Rome 54
Moscow 52
Eugene 50
Jakarta 50
Buffalo 47
Shanghai 47
Bologna 46
São Paulo 42
Orem 41
Tampa 38
Elk Grove Village 33
Falls Church 32
Fremont 32
Boardman 31
Turku 27
Warsaw 26
Frankfurt am Main 25
Bremen 24
Phoenix 24
Sterling 24
Dong Ket 23
Ottawa 23
Naples 21
Mexico City 19
Brooklyn 18
Brussels 18
Denver 17
Lahore 17
Redwood City 17
Boston 16
Dhaka 16
Haiphong 16
Norwalk 16
Mumbai 15
Redondo Beach 15
Atlanta 14
Johannesburg 14
Lancaster 14
Nuremberg 14
Parma 14
Da Nang 13
Stockholm 13
Chennai 12
Tashkent 12
Toronto 12
Baghdad 11
Brno 11
Lansdale 11
Manchester 11
Florence 10
Hyderabad 10
Miano 10
Santiago 10
Amsterdam 9
Baku 9
Brasília 9
Des Moines 9
Grafing 9
Totale 12.608
Salva come PNG Salva come JPEG
Nome #
Poorly differentiated clusters (PDC) in colorectal cancer: What is and ought to be known. 461
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 448
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 435
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 434
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour 422
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 409
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 402
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 386
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 378
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 369
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 368
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 367
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 361
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 350
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 345
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 329
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 329
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients 326
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 326
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 325
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 320
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 318
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 315
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 313
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 310
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 308
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 306
Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. 305
Expression of estrogen receptor in hemangioma of the uterine cervix: Reports of three cases and review of the literature 294
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 293
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 285
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 279
Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation 279
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 277
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. 276
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 272
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 272
EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature 272
Clinical impact and prognostic role of KRAS/BRAF/PIK3CA mutations in stage I colorectal cancer 271
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 270
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 269
Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer. 261
The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung 260
Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization 259
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 245
Preoperative letrozole plus lapatinib/placebo for HR+/HER2 negative operable breast cancer: biomarker analyses of the randomized phase II LET-LOB study 243
Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung 239
High-Resolution Melting is a sensitive, cost-effective, time-saving technique for BRAF V600E detection in thyroid FNAB washing fluid: a prospective cohort study 231
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 224
Correlation between CD133 expression and mgmt status in recurrences melanoma 224
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 219
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 219
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 216
KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: Observational analysis of 175 cases 212
FISH analysis in cell touch preparations and cytological specimens from formalin-fixed fetal autopsies 208
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 207
Evaluation of the effects of cryopreservation on Modena Biobank tissue samples through HR-MAS NMR 197
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 196
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 187
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 174
Morphological analysis of three extrathoracic bronchogenic cysts simulating neoplasms 164
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 153
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy (British Journal of Cancer, (2010), 103, 7, (1019-1024), 10.1038/sj.bjc.6605853) 84
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients 82
A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes 41
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study 10
Totale 18.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022999 0 0 94 71 40 91 54 58 121 123 202 145
2022/20231.520 149 164 117 122 121 178 35 115 400 13 46 60
2023/2024937 18 53 47 91 160 68 194 114 23 21 55 93
2024/20252.807 77 30 78 217 565 446 201 159 313 138 220 363
2025/20266.397 410 192 492 727 1.147 412 732 313 555 505 496 416
2026/2027522 166 339 17 0 0 0 0 0 0 0 0 0
Totale 18.429